Background Acute myeloid leukemia is the second most common leukemia among United
States adults with a median age of 69 years. We investigated recent clinical practices related …

BACKGROUND: Acute myeloid leukemia (AML) is associated with a poor prognosis,
particularly in older patients. To the authors' knowledge, few population‐based studies of …

Introduction Acute myeloid leukaemia (AML) is the most common type of leukaemia among
adults in the US. However, data on longitudinal treatment patterns and outcomes associated …

BACKGROUND Acute myeloid leukemia (AML) is the common form of acute leukemia in
adults, accounting for over 80% of all acute leukemias in individuals aged> 18 years. Overall …

Acute myeloid leukemia (AML) is predominantly a disease of older adults, with a median
age at diagnosis of over 65 years. AML in older adults differs biologically and clinically from …

Abstract Treatment of adults with acute myeloblastic leukemia has changed substantially
over the past two decades. Currently available estimates of survival do not reflect results …

Acute myeloid leukemia (AML) is a disease of older adults, with a median age of 67 years at
presentation. In the past, only a third of older patients (defined as individuals older than 60 …

BACKGROUND Health care utilization in older adults (age≥ 60 years) with acute myeloid
leukemia (AML) has not been well studied. METHODS We conducted a retrospective …

BACKGROUND AND OBJECTIVES: The prognosis of elderly patients with acute
myelogenous leukemia (AML) is usually dismal, while the true survival of older patients not …

Background In patients over age 60 with acute myeloid leukemia (AML), cure rates are
under 10% despite intensive chemotherapy. These patients often have comorbidities, and …